课题基金 / 基金详情

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY
血管紧张素转换酶 (ACE) 抑制剂治疗镰状细胞肾病患者
批准号：
6275092
负责人：
Ronald J Falk
金额：
$1.58万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6275092
关键词：
ACE inhibitors blood disorder chemotherapy chemoprevention chronic renal failure clinical research disease /disorder prevention /control drug screening /evaluation human subject human therapy evaluation kidney disorder chemotherapy peptidyl dipeptidase A proteinuria sickle cell anemia

项目摘要

项目成果

Ronald J Falk的其他基金

相关文献

中文摘要
翻译
本研究的目的是确定是否使用血管紧张素
英文摘要
The purpose of this study is to determine if the use of angiotensin converting enzyme (ACE) inhibitor prevents the development of renal insufficiency and reduces proteinuria in patients with sickle cell nephropathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRIO Administrative Core
GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases
GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases
GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases